Bill Text: CA SB524 | 2023-2024 | Regular Session | Amended
Bill Title: Pharmacists: furnishing prescription medications.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Failed) 2024-02-01 - Returned to Secretary of Senate pursuant to Joint Rule 56. [SB524 Detail]
Download: California-2023-SB524-Amended.html
Amended
IN
Senate
March 20, 2023 |
Introduced by Senator Caballero |
February 14, 2023 |
LEGISLATIVE COUNSEL'S DIGEST
The Pharmacy Law establishes the California State Board of Pharmacy to administer its provisions and authorizes a pharmacist to, among other things, perform certain procedures or functions in a licensed health care facility, as specified.
This bill would make a nonsubstantive change to that provision.
Digest Key
Vote: MAJORITY Appropriation: NO Fiscal Committee:Bill Text
The people of the State of California do enact as follows:
SECTION 1.
Section 4052 of the Business and Professions Code is amended to read:4052.
(a) Notwithstanding any other law, a pharmacist may do all of the following:(iv)
(v)
SEC. 2.
Section 4052.04 is added to the Business and Professions Code, to read:4052.04.
(a) Notwithstanding any other law, a pharmacist may furnish prescriptions pursuant to the result from a test, as authorized by Section 4052.4, that is used to guide diagnosis or clinical decisionmaking.SEC. 3.
Section 4052.4 of the Business and Professions Code is amended to read:4052.4.
(a) Notwithstanding Section 2038 or any other provision of law, a pharmacist may perform skin puncture in the course of performing routine patient assessment procedures or in the course of performing any procedure authorized under Section 1206.5 or 1206.6. For purposes of this section, “routine patient assessment procedures” means: (a) procedures that a patient could, with or without a prescription, perform for themselves, or (b) clinical laboratory tests that are classified as waived pursuant to the federal Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. Sec. 263a) and the regulations adopted thereunder by the federal Health Care Financing Administration, as authorized by paragraph (11) of subdivision (a) of Section 1206.5 or Section 1206.6. A pharmacist performing these functions shall report the results obtained from a test to the patient and any physician designated by the patient. A pharmacist may furnish prescriptions pursuant to the result from a routine patient assessment procedure, as authorized by this section, used to guide diagnosis or clinical decisionmaking. Any pharmacist who performs the service authorized by this section shall not be in violation of Section 2052.SEC. 4.
Section 14132.968 of the Welfare and Institutions Code is amended to read:14132.968.
(a) (1) Pharmacist services are a benefit under the Medi-Cal program, subject to approval by the federal Centers for Medicare and Medicaid Services.SEC. 5.
No reimbursement is required by this act pursuant to Section 6 of Article XIII B of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIII B of the California Constitution.(a)Notwithstanding any other law, a pharmacist may do all of the following:
(1)Furnish a reasonable quantity of compounded drug product to a prescriber for office use by the prescriber.
(2)Transmit a valid prescription to another pharmacist.
(3)Administer drugs and biological products that have been ordered by a prescriber.
(4)Perform procedures or functions in a licensed health care facility,
as authorized by Section 4052.1.
(5)Perform procedures or functions as part of the care provided by a health care facility, a licensed home health agency, a licensed clinic in which there is physician oversight, a provider who contracts with a licensed health care service plan with regard to the care or services provided to the enrollees of that health care service plan, or a physician, as authorized by Section 4052.2.
(6)Perform procedures or functions as authorized by Section 4052.6.
(7)Manufacture, measure, fit to the patient, or sell and repair dangerous devices, or furnish instructions to the patient or the patient’s representative concerning the use of those devices.
(8)Provide consultation, training, and education to patients about drug
therapy, disease management, and disease prevention.
(9)Provide professional information, including clinical or pharmacological information, advice, or consultation to other health care professionals, and participate in multidisciplinary review of patient progress, including appropriate access to medical records.
(10)Furnish the medications described in subparagraph (A) in accordance with subparagraph (B):
(A)(i)Emergency contraception drug therapy and self-administered hormonal contraceptives, as authorized by Section 4052.3.
(ii)Nicotine replacement products, as authorized by Section 4052.9.
(iii)Prescription medications not requiring a diagnosis that are
recommended by the federal Centers for Disease Control and Prevention for individuals traveling outside of the United States.
(iv)HIV preexposure prophylaxis, as authorized by Section 4052.02.
(v)HIV postexposure prophylaxis, as authorized by Section 4052.03.
(B)The pharmacist shall notify the patient’s primary care provider of any drugs or devices furnished to the patient, or enter the appropriate information in a patient record system shared with the primary care provider, as permitted by that primary care provider. If the patient does not have a primary care provider, the pharmacist shall provide the patient with a written record of the drugs or devices furnished and advise the patient to consult a physician of the patient’s choice.
(11)Administer immunizations pursuant to a protocol with a prescriber.
(12)Order and interpret tests for the purpose of monitoring and managing the efficacy and toxicity of drug therapies. A pharmacist who orders and interprets tests pursuant to this paragraph shall ensure that the ordering of those tests is done in coordination with the patient’s primary care provider or diagnosing prescriber, as appropriate, including promptly transmitting written notification to the patient’s diagnosing prescriber or entering the appropriate information in a patient record system shared with the prescriber, when available and as permitted by that prescriber.
(13)Initiate, adjust, or discontinue drug therapy for a patient under a collaborative practice agreement with any health care provider with prescriptive authority. The collaborative practice agreement may be between a single
or multiple pharmacists and a single or multiple health care providers with prescriptive authority.
(14)Provide medication-assisted treatment pursuant to a state protocol, to the extent authorized by federal law.
(b)A pharmacist who is authorized to issue an order to initiate or adjust a controlled substance therapy pursuant to this section shall personally register with the federal Drug Enforcement Administration.
(c)This section does not affect the applicable requirements of law relating to either of the following:
(1)Maintaining the confidentiality of medical records.
(2)The licensing of a health care facility.